secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0000310764-24-000113
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q3 beats: adj EPS $2.87 (+16.7%), sales $5.5B (+11.5% organic), raises FY guidance
--------------------------------------------------------------------------------

- Reported net sales $5.5B, +11.9% reported, +11.5% organic; adjusted EPS $2.87, +16.7%.
- Adjusted operating margin expanded 130bps to 24.7%.
- MedSurg & Neurotechnology organic sales +12.7%; Orthopaedics & Spine +9.7%.
- FY2024 guidance raised: organic sales growth 9.5%-10.0%, adjusted EPS $12.00-$12.10.
- CEO cites product innovation and acquisitions as growth drivers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076424000113/0000310764-24-000113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076424000113/syk-20241029.htm
  HTML page:      https://secwatch.observer/filing/0000310764-24-000113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer